Conference Coverage (ISV)

T-Cell Vaccines Via Genetic, Enzymatic, Chemical Engineering

Published in TB and Outbreaks Week, September 22nd, 1997

Vaccines that efficiently elicit T-cell mediated immune responses can be created via genetic, enzymatic, and/or chemical engineering.

These various approaches create immunogenic chimeric molecules by combining T-cell antigens with self molecules.

"Viral peptides delivered by chimeric self molecules are more immunogenic than peptides alone and can induce a strong cellular immune response in vitro and in vivo," said Constatin A. Bona of the Mt. Sinai School of Medicine, New York.

Bona described the approach in an address to the first annual International Society for Vaccines Symposium on Vaccinology, held September 8-11, 1997, in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1997-09-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry